TY - JOUR
T1 - Parental measurement of height in growth hormone-treated children in the hospital setting proves valid
T2 - an observational study - potential for replacement of outpatient clinic visits to the home setting
AU - Remmits, Anouk J W
AU - van Mastrigt, Ghislaine A P G
AU - Evers, Silvia M A A
AU - der Grinten, Hedi L Claahsen-van
AU - van Setten, Petra A
PY - 2024/3
Y1 - 2024/3
N2 - Reliable height measurement plays a pivotal role in evaluating the efficacy of costly growth hormone (GH) therapy in children. Currently, regularly outpatient clinic visits are needed to accurately measure height. The outpatient clinic visits are time-consuming for parents as well for health care professionals. This observational study aimed to investigate the validity of parentally performed height measurements compared to height measurements in the outpatient setting. An observational study was performed at the outpatient clinic of Amalia’s Children’s Hospital Nijmegen. A portable stadiometer (PS) was developed for height measurements at home. Measurements with the PS were performed by the researcher (PSR) and parents/caregivers (PSP). Measurements performed with the electronic digital ruler (EDS) were considered as the gold standard. The parents were potentially unblinded for the gold standard measurement (EDS). Descriptive statistics, Wilcoxon signed-rank, and Pearson’s correlation tests were performed. The Bland–Altman plots were made to illustrate the correlation of the PSR or PSP with the gold standard. The correlation between the height measurements with PSR or PSP compared to the EDS was substantial (PSR: r = 0.9998, R
2 = 0.9996, P < 0.001; PSP: r = 0.9998, R
2 = 0.9995, P < 0.001). However, a statistically significant underestimation of the PSR and PSP was observed (P < 0.001). The mean difference of the PSR and PSP was respectively − 0.21 cm ± 0.52 SD and − 0.30 cm ± 0.62 SD in comparison to the EDS. The Bland–Altman plots illustrated that 95% of the PSR measurements were between − 1.03 and 0.60 cm and 95% of the PSP measurements were between − 1.26 and 0.66 cm compared to the EDS. Conclusion: We found a strong correlation between the PSR or PSP and the EDS, with only a minor underestimation of approximately 0.2–0.3 cm. In our opinion, this underestimation is clinically irrelevant as it does not result in an adjustment in GH dose. To conclude, parental height measurements could be a promising tool as it partially replaces outpatient clinic visits needed for measurements of height. Further studies are required to confirm this statement. (Table presented.)
AB - Reliable height measurement plays a pivotal role in evaluating the efficacy of costly growth hormone (GH) therapy in children. Currently, regularly outpatient clinic visits are needed to accurately measure height. The outpatient clinic visits are time-consuming for parents as well for health care professionals. This observational study aimed to investigate the validity of parentally performed height measurements compared to height measurements in the outpatient setting. An observational study was performed at the outpatient clinic of Amalia’s Children’s Hospital Nijmegen. A portable stadiometer (PS) was developed for height measurements at home. Measurements with the PS were performed by the researcher (PSR) and parents/caregivers (PSP). Measurements performed with the electronic digital ruler (EDS) were considered as the gold standard. The parents were potentially unblinded for the gold standard measurement (EDS). Descriptive statistics, Wilcoxon signed-rank, and Pearson’s correlation tests were performed. The Bland–Altman plots were made to illustrate the correlation of the PSR or PSP with the gold standard. The correlation between the height measurements with PSR or PSP compared to the EDS was substantial (PSR: r = 0.9998, R
2 = 0.9996, P < 0.001; PSP: r = 0.9998, R
2 = 0.9995, P < 0.001). However, a statistically significant underestimation of the PSR and PSP was observed (P < 0.001). The mean difference of the PSR and PSP was respectively − 0.21 cm ± 0.52 SD and − 0.30 cm ± 0.62 SD in comparison to the EDS. The Bland–Altman plots illustrated that 95% of the PSR measurements were between − 1.03 and 0.60 cm and 95% of the PSP measurements were between − 1.26 and 0.66 cm compared to the EDS. Conclusion: We found a strong correlation between the PSR or PSP and the EDS, with only a minor underestimation of approximately 0.2–0.3 cm. In our opinion, this underestimation is clinically irrelevant as it does not result in an adjustment in GH dose. To conclude, parental height measurements could be a promising tool as it partially replaces outpatient clinic visits needed for measurements of height. Further studies are required to confirm this statement. (Table presented.)
KW - Height
KW - Parentally reported
KW - Portable stadiometer
KW - Transitioning outpatient visits to home care
KW - Validity
U2 - 10.1007/s00431-023-05232-5
DO - 10.1007/s00431-023-05232-5
M3 - Article
SN - 0340-6199
VL - 183
SP - 1145
EP - 1152
JO - European Journal of Pediatrics
JF - European Journal of Pediatrics
IS - 3
ER -